{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T05:56:57Z","timestamp":1778392617959,"version":"3.51.4"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Public Health"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.puhe.2021.01.004","type":"journal-article","created":{"date-parts":[[2021,1,17]],"date-time":"2021-01-17T23:59:09Z","timestamp":1610927949000},"page":"8-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["Preliminary indications of the burden of COVID-19 among people who inject drugs in England and Northern Ireland and the impact on access to health and harm reduction services"],"prefix":"10.1016","volume":"192","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2220-623X","authenticated-orcid":false,"given":"S.","family":"Croxford","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5607-459X","authenticated-orcid":false,"given":"E.","family":"Emanuel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Ibitoye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Njoroge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Edmundson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9690-6493","authenticated-orcid":false,"given":"M.","family":"Bardsley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Heinsbroek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5712-5734","authenticated-orcid":false,"given":"V.","family":"Hope","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Phipps","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.puhe.2021.01.004_bib1","article-title":"Challenges posed by COVID-19 to people who inject drugs and lessons from other outbreaks","volume":"23","author":"Vasylyeva","year":"2020","journal-title":"J\u00a0Int AIDS Soc"},{"key":"10.1016\/j.puhe.2021.01.004_bib2","series-title":"EMCDDA update on the implications of COVID-19 for people who use drugs (PWUD) and drug service providers","year":"2020"},{"key":"10.1016\/j.puhe.2021.01.004_bib3","doi-asserted-by":"crossref","first-page":"102895","DOI":"10.1016\/j.drugpo.2020.102895","article-title":"Drug use during a pandemic: convergent risk of novel coronavirus and invasive bacterial and viral infections among people who use drugs","volume":"83","author":"Jacka","year":"2020","journal-title":"Int J Drug Pol"},{"issue":"6","key":"10.1016\/j.puhe.2021.01.004_bib4","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1111\/add.15080","article-title":"Mitigating and learning from the impact of COVID-19 infection on addictive disorders","volume":"115","author":"Marsden","year":"2020","journal-title":"Addiction"},{"key":"10.1016\/j.puhe.2021.01.004_bib5","series-title":"Unlinked Anonymous Monitoring (UAM) Survey of HIV and viral hepatitis among PWID: 2020 report","year":"2020"},{"key":"10.1016\/j.puhe.2021.01.004_bib6","doi-asserted-by":"crossref","first-page":"108302","DOI":"10.1016\/j.drugalcdep.2020.108302","article-title":"COVID-19 survey among people who use drugs in three cities in Norway","volume":"217","author":"Welle-Strand","year":"2020","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.puhe.2021.01.004_bib7","series-title":"Shooting Up: infections among people who inject drugs in the UK, 2019 - an update, December 2020","year":"2020"},{"key":"10.1016\/j.puhe.2021.01.004_bib8","series-title":"Coronavirus triggers UK shortage of illicit drugs","author":"Grierson","year":"2020"},{"key":"10.1016\/j.puhe.2021.01.004_bib9","doi-asserted-by":"crossref","first-page":"102851","DOI":"10.1016\/j.drugpo.2020.102851","article-title":"The impact of COVID-19 restrictions on needle and syringe programme provision and coverage in England","volume":"83","author":"Whitfield","year":"2020","journal-title":"Int J Drug Pol"},{"key":"10.1016\/j.puhe.2021.01.004_bib10","series-title":"COVID-19: guidance for commissioners and providers of services for people who use drugs or alcohol","year":"2020"}],"container-title":["Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003335062100010X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003335062100010X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:34:04Z","timestamp":1758501244000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S003335062100010X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":10,"alternative-id":["S003335062100010X"],"URL":"https:\/\/doi.org\/10.1016\/j.puhe.2021.01.004","relation":{},"ISSN":["0033-3506"],"issn-type":[{"value":"0033-3506","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preliminary indications of the burden of COVID-19 among people who inject drugs in England and Northern Ireland and the impact on access to health and harm reduction services","name":"articletitle","label":"Article Title"},{"value":"Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.puhe.2021.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2021 Published by Elsevier Ltd on behalf of The Royal Society for Public Health. All rights reserved.","name":"copyright","label":"Copyright"}]}}